PFM Health Sciences’s Dermira, Inc. DERM Stock Holding History

PFM Health Sciences’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,271,180	Closed	-$34.4M	–	85
2019 Q4	$34.4M	Sell	2,271,180 -1,558,356	-41%	-$13.5M	1.64%	22
2019 Q3	$24.5M	Sell	3,829,536 -215,006	-5%	-$1.8M	0.72%	43
2019 Q2	$38.7M	Buy	4,044,542 +1,463,509	+57%	+$15.8M	0.73%	46
2019 Q1	$35M	Buy	+2,581,033	New	+$21.5M	0.77%	44

PFM Health Sciences's DERM Position: Q1 2020 in Review

PFM Health Sciences sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 2,271,180 shares — an estimated $34.4M sold.

PFM Health Sciences first reported a position in DERM in Q1 2019 and held it in 4 quarters. The position peaked at $38.7M in Q2 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

PFM Health Sciences reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
PFM Health Sciences sold 2,271,180 Dermira, Inc. shares in Q1 2020, an estimated $34.4M.
PFM Health Sciences first reported a position in Dermira, Inc. in Q1 2019 and held it in 4 quarters.
PFM Health Sciences's Dermira, Inc. position peaked at $38.7M in Q2 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.